Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD.

Culpitt SV, Rogers DF, Fenwick PS, Shah P, De Matos C, Russell RE, Barnes PJ, Donnelly LE.

Thorax. 2003 Nov;58(11):942-6.

2.

Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.

Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, Barnes PJ.

Am J Respir Crit Care Med. 2003 Jan 1;167(1):24-31. Epub 2002 Sep 17.

PMID:
12406856
3.

Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.

Knobloch J, Sibbing B, Jungck D, Lin Y, Urban K, Stoelben E, Strauch J, Koch A.

J Pharmacol Exp Ther. 2010 Dec;335(3):788-98. doi: 10.1124/jpet.110.166843. Epub 2010 Aug 26.

4.

Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease.

Knobloch J, Hag H, Jungck D, Urban K, Koch A.

Basic Clin Pharmacol Toxicol. 2011 Aug;109(2):138-43. doi: 10.1111/j.1742-7843.2011.00707.x. Epub 2011 May 6.

5.

Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease.

Armstrong J, Harbron C, Lea S, Booth G, Cadden P, Wreggett KA, Singh D.

J Pharmacol Exp Ther. 2011 Sep;338(3):732-40. doi: 10.1124/jpet.111.180737. Epub 2011 May 24.

6.

Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages.

Armstrong J, Sargent C, Singh D.

Clin Exp Immunol. 2009 Oct;158(1):74-83. doi: 10.1111/j.1365-2249.2009.03986.x.

7.

Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.

Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ.

Am J Respir Cell Mol Biol. 2002 May;26(5):602-9.

PMID:
11970913
8.

Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.

Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, Dombret MC, Sims GP, Kolbeck R, Coyle AJ, Aubier M, Pretolani M.

Am J Respir Crit Care Med. 2010 May 1;181(9):917-27. doi: 10.1164/rccm.200903-0340OC. Epub 2010 Feb 4.

PMID:
20133931
9.

Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis.

Oltmanns U, Schmidt B, Hoernig S, Witt C, John M.

Exp Lung Res. 2003 Jul;29(5):315-28.

PMID:
12746045
10.

Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease.

Knobloch J, Wahl C, Feldmann M, Jungck D, Strauch J, Stoelben E, Koch A.

Basic Clin Pharmacol Toxicol. 2014 Feb;114(2):202-9. doi: 10.1111/bcpt.12129. Epub 2013 Sep 30.

11.

Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.

Profita M, Chiappara G, Mirabella F, Di Giorgi R, Chimenti L, Costanzo G, Riccobono L, Bellia V, Bousquet J, Vignola AM.

Thorax. 2003 Jul;58(7):573-9.

13.

Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.

Kunz LI, Lapperre TS, Snoeck-Stroband JB, Budulac SE, Timens W, van Wijngaarden S, Schrumpf JA, Rabe KF, Postma DS, Sterk PJ, Hiemstra PS; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group.

Respir Res. 2011 Mar 22;12:34. doi: 10.1186/1465-9921-12-34.

14.

Cigarette smoke augments the expression and responses of toll-like receptor 3 in human macrophages.

Koarai A, Yanagisawa S, Sugiura H, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M.

Respirology. 2012 Aug;17(6):1018-25. doi: 10.1111/j.1440-1843.2012.02198.x.

PMID:
22591330
15.

Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.

Thomassen MJ, Yi T, Raychaudhuri B, Malur A, Kavuru MS.

Clin Immunol. 2000 May;95(2):85-92.

PMID:
10779401
16.

Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms.

Donnelly LE, Newton R, Kennedy GE, Fenwick PS, Leung RH, Ito K, Russell RE, Barnes PJ.

Am J Physiol Lung Cell Mol Physiol. 2004 Oct;287(4):L774-83. Epub 2004 Jun 4.

17.

Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects.

Gerlach K, Köhler-Bachmann S, Jungck D, Körber S, Yanik S, Knoop H, Wehde D, Rheinländer S, Walther JW, Kronsbein J, Knobloch J, Koch A.

Eur J Pharmacol. 2015 Dec 5;768:123-30. doi: 10.1016/j.ejphar.2015.10.040. Epub 2015 Oct 23.

PMID:
26526351
18.

Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease.

Suzuki M, Betsuyaku T, Ito Y, Nagai K, Nasuhara Y, Kaga K, Kondo S, Nishimura M.

Am J Respir Cell Mol Biol. 2008 Dec;39(6):673-82. doi: 10.1165/rcmb.2007-0424OC. Epub 2008 Jun 19.

PMID:
18566336
19.

Klotho Reduction in Alveolar Macrophages Contributes to Cigarette Smoke Extract-induced Inflammation in Chronic Obstructive Pulmonary Disease.

Li L, Wang Y, Gao W, Yuan C, Zhang S, Zhou H, Huang M, Yao X.

J Biol Chem. 2015 Nov 13;290(46):27890-900. doi: 10.1074/jbc.M115.655431. Epub 2015 Sep 18.

20.

Supplemental Content

Support Center